(Adds futures and news items)
Feb 3 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 15 points
higher at 6,531 on Wednesday, according to financial bookmakers, with futures
.FFIc1 up 0.47% ahead of cash market open.
* VODAFONE: Vodafone VOD.L said organic service revenue returned to growth
in its third quarter, with a rise of 0.4% soundly beating analysts' expectations
for a fall of 0.1%. * GSK: Britain's GlaxoSmithKline GSK.L and German biotech firm CureVac
5CV.DE struck a 150-million-euro deal to develop next-generation vaccines
against COVID-19 that target several variants in one product. * FERGUSON: Ferguson FERG.L said it expects its additional share listing
on the New York Stock Exchange to be effective in early March. * GLENCORE: Glencore GLEN.L said copper and cobalt production fell in
2020 after the closure of its Mutanda mine in Democratic Republic of Congo
mine. * ASTRAZENECA: Oxford University and AstraZeneca's COVID-19 vaccine showed
in a study it had 76% efficacy against symptomatic infection for three months
after a single dose, which increased if the second shot is delayed. * BHP: Lawyers for about 200,000 Brazilian claimants, whose multi-billion
dollar lawsuit against miner BHP BHPB.L , BHP.AX over a 2015 dam collapse was
struck down last November, said they will petition the English Court of Appeal
to review the case. * SILVER: Silver attempted a rebound after an over 8% plunge in the previous
session prompted investors to buy in. * OIL: Oil prices rose in Asia after hitting their highest in about a year
in the previous session. * The UK blue-chip index .FTSE closed 0.8% higher on Tuesday following
optimism about economic stimulus and a faster global recovery, while oil
manufacturing major BP BP.L dropped after reporting weak earnings. For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB